RT Journal Article
SR Electronic
T1 Using Digital Surveillance Tools for Near Real-Time Mapping of the Risk of International Infectious Disease Spread: Ebola as a Case Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19011940
DO 10.1101/19011940
A1 Bhatia, Sangeeta
A1 Lassmann, Britta
A1 Cohn, Emily
A1 Carrion, Malwina
A1 Kraemer, Moritz U. G.
A1 Herringer, Mark
A1 Brownstein, John
A1 Madoff, Larry
A1 Cori, Anne
A1 Nouvellet, Pierre
YR 2019
UL http://medrxiv.org/content/early/2019/11/15/19011940.abstract
AB In our increasingly interconnected world, it is crucial to understand the risk of an outbreak originating in one country or region and spreading to the rest of the world. Digital disease surveillance tools such as ProMED and HealthMap have the potential to serve as important early warning systems as well as complement the field surveillance during an ongoing outbreak. Here we present a flexible statistical model that uses data produced from digital surveillance tools (ProMED and HealthMap) to forecast short term incidence trends in a spatially explicit manner. The model was applied to data collected by ProMED and HealthMap during the 2013-2016 West African Ebola epidemic. The model was able to predict each instance of international spread 1 to 4 weeks in advance. Our study highlights the potential and limitations of using publicly available digital surveillance data for assessing outbreak dynamics in real-time.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work in this manuscript was funded through the USAID (United States Agency of International Development) Center for Accelerating Innovation and Impact - "Combating Zika and Future Threats: A Grand Challenge for Development" Program (Award No. AID-0AA-F-16-00115). The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the USAID. SB, AC and PN acknowledge joint Centre funding from the UK Medical Research Council and Department for International Development (MR/R015600/1), funding from the UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London in partnership with Public Health England (PHE) (HPRU-2012-10080), and funding from the Bill and Melinda Gates Foundation (OPP1092240).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study are available online. https://github.com/sangeetabhatia03/mriids_manuscript/tree/v1.0